FTC sues main pharmacy advantage professionals around insulin rates The agency introduced motion in opposition to Caremark, Specific Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating methods “artificially inflated” the list cost of lifetime-conserving insulin medications. Sanders quickly condemned the go in an announcement Wednesday, noting he was https://kethek.com/